Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1988 Jun 1;167(6):1999–2004. doi: 10.1084/jem.167.6.1999

Complement activation is required for IgM-mediated enhancement of the antibody response

PMCID: PMC2189680  PMID: 3385360

Abstract

The ability of IgM antibodies to specifically enhance the thymus- dependent humoral immune response to particulate antigens is well documented. We have used two approaches to test whether complement factors play a role in this process. First, mice were depleted of C3 by treatment with cobra venom factor (CVF) and then immunized with SRBC with or without IgM-anti-SRBC. CVF treatment severely impaired the capacity of IgM to induce an enhanced anti-SRBC response. Moreover, it was shown that IgM can potentiate the response in C5-deficient AKR mice, thus demonstrating that the complement factors acting before C5 are the crucial ones. A second test compared the enhancing properties of two monoclonal IgM-anti-TNP antibodies where, because of a point mutation in the mu chain constant region, one of the antibodies is impaired in its capacity to activate complement. We show that the mutant antibody lacks the enhancing properties of the wild-type IgM. Activation of C3 by IgM antibodies as well as localization of antigen in the spleen seem to be necessary steps in the IgM-mediated enhancement of antibody responses. Our data offer an explanation to the immunosuppression described in CVF-treated animals as well as the low humoral immune responses in certain hereditary complement deficiencies. It is suggested that IgM indeed has an important physiological function in enhancing antibody responses to foreign substances.

Full Text

The Full Text of this article is available as a PDF (365.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Böttger E. C., Hoffmann T., Metzger S., Hadding U., Bitter-Suermann D. The role and mechanism of cobra venom factor-induced suppression of the humoral immune response in guinea pigs. J Immunol. 1986 Aug 15;137(4):1280–1285. [PubMed] [Google Scholar]
  2. CINADER B., DUBISKI S., WARDLAW A. C. DISTRIBUTION, INHERITANCE, AND PROPERTIES OF AN ANTIGEN, MUB1, AND ITS RELATION TO HEMOLYTIC COMPLEMENT. J Exp Med. 1964 Nov 1;120:897–924. doi: 10.1084/jem.120.5.897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Coulie P. G., Van Snick J. Enhancement of IgG anti-carrier responses by IgG2 anti-hapten antibodies in mice. Eur J Immunol. 1985 Aug;15(8):793–798. doi: 10.1002/eji.1830150810. [DOI] [PubMed] [Google Scholar]
  4. Dennert G. The mechanism of antibody-induced stimulation and inhibition of the immune response. J Immunol. 1971 Apr;106(4):951–955. [PubMed] [Google Scholar]
  5. Erdei A., Melchers F., Schulz T., Dierich M. The action of human C3 in soluble or cross-linked form with resting and activated murine B lymphocytes. Eur J Immunol. 1985 Feb;15(2):184–188. doi: 10.1002/eji.1830150214. [DOI] [PubMed] [Google Scholar]
  6. Harte P. G., Cooke A., Playfair J. H. Specific monoclonal IgM is a potent adjuvant in murine malaria vaccination. Nature. 1983 Mar 17;302(5905):256–258. doi: 10.1038/302256a0. [DOI] [PubMed] [Google Scholar]
  7. Heinen E., Radoux D., Kinet-Denoel C., Moeremans M., De Mey J., Simar L. J. Isolation of follicular dendritic cells from human tonsils and adenoids. III. Analysis of their Fc receptors. Immunology. 1985 Apr;54(4):777–784. [PMC free article] [PubMed] [Google Scholar]
  8. Henry C., Jerne N. K. Competition of 19S and 7S antigen receptors in the regulation of the primary immune response. J Exp Med. 1968 Jul 1;128(1):133–152. doi: 10.1084/jem.128.1.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Heyman B., Andrighetto G., Wigzell H. Antigen-dependent IgM-mediated enhancement of the sheep erythrocyte response in mice. Evidence for induction of B cells with specificities other than that of the injected antibodies. J Exp Med. 1982 Apr 1;155(4):994–1009. doi: 10.1084/jem.155.4.994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Heyman B., Hobbs M. V., Weigle W. O. IgM-mediated enhancement of in vivo anti-sheep erythrocyte antibody responses: isotype analysis of the enhanced responses. Cell Immunol. 1985 Apr 15;92(1):134–141. doi: 10.1016/0008-8749(85)90071-1. [DOI] [PubMed] [Google Scholar]
  11. Heyman B., Holmquist G., Borwell P., Heyman U. An enzyme-linked immunosorbent assay for measuring anti-sheep erythrocyte antibodies. J Immunol Methods. 1984 Mar 30;68(1-2):193–204. doi: 10.1016/0022-1759(84)90150-9. [DOI] [PubMed] [Google Scholar]
  12. Jackson C. G., Ochs H. D., Wedgwood R. J. Immune response of a patient with deficiency of the fourth component of complement and systemic lupus erythematosus. N Engl J Med. 1979 May 17;300(20):1124–1129. doi: 10.1056/NEJM197905173002002. [DOI] [PubMed] [Google Scholar]
  13. Kevy S. V., Tefft M., Vawier G. F., Rosen F. S. Hereditary splenic hypoplasia. Pediatrics. 1968 Nov;42(5):752–757. [PubMed] [Google Scholar]
  14. Klaus G. G. Generation of memory cells. III. Antibody class requirements for the generation of B-memory cells by antigen--antibody complexes. Immunology. 1979 Jun;37(2):345–351. [PMC free article] [PubMed] [Google Scholar]
  15. McBride R. A., Schierman L. W. Thymus dependency of antibody-mediated helper effect. J Immunol. 1973 Jun;110(6):1710–1712. [PubMed] [Google Scholar]
  16. Papamichail M., Gutierrez C., Embling P., Johnson P., Holborow E. J., Pepys M. B. Complement dependence of localisation of aggregated IgG in germinal centres. Scand J Immunol. 1975;4(4):343–347. doi: 10.1111/j.1365-3083.1975.tb02635.x. [DOI] [PubMed] [Google Scholar]
  17. Pepys M. B. Role of complement in induction of antibody production in vivo. Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses. J Exp Med. 1974 Jul 1;140(1):126–145. doi: 10.1084/jem.140.1.126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Pepys M. B. Studies in vivo of cobra factor and murine C3. Immunology. 1975 Feb;28(2):369–377. [PMC free article] [PubMed] [Google Scholar]
  19. Rittenberg M. B., Pratt K. L. Antitrinitrophenyl (TNP) plaque assay. Primary response of Balb/c mice to soluble and particulate immunogen. Proc Soc Exp Biol Med. 1969 Nov;132(2):575–581. doi: 10.3181/00379727-132-34264. [DOI] [PubMed] [Google Scholar]
  20. Schrader J. W. Regulation of the immune response by IgM antibody: a paradoxical suppression of the in vitro primary immune response to sheep erythrocytes by passive IgM. Aust J Exp Biol Med Sci. 1973 Jun;51(3):333–346. doi: 10.1038/icb.1973.32. [DOI] [PubMed] [Google Scholar]
  21. Shulman M. J., Collins C., Pennell N., Hozumi N. Complement activation by IgM: evidence for the importance of the third constant domain of the mu heavy chain. Eur J Immunol. 1987 Apr;17(4):549–554. doi: 10.1002/eji.1830170418. [DOI] [PubMed] [Google Scholar]
  22. von Zabern I., Hinsch B., Przyklenk H., Schmidt G., Vogt W. Comparison of Naja n. naja and Naja h. haje cobra-venom factors: correlation between binding affinity for the fifth component of complement and mediation of its cleavage. Immunobiology. 1980 Dec;157(4-5):499–514. doi: 10.1016/s0171-2985(80)80018-0. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES